Astellas Pharma Inc. is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need. Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, marrying nearly two centuries of collective experience in producing medicines. We combine the deep expertise brought by this long heritage with the forward-thinking outlook of a young company. At the heart of that outlook is the patient. We have defined five therapeutic areas as our priorities for improving the future of patients in Europe: Oncology, Transplantation, Urology, Anti-Infectives and Pain Management.